Oncology

LYON, France — September 18, 2026 MaaT Pharma announced that the Committee for Medicinal Products for Human Use (CHMP)...

SEATTLE, Wash. — September 17, 2026 Adaptive Biotechnologies highlighted updates to the National Comprehensive Cancer Network (NCCN) Guidelines for...

MIAMI, Fla. — September 17, 2026 Telomir Pharmaceuticals announced the peer-reviewed publication of new preclinical research showing that Telomir-Zn...

LONDON and PHILADELPHIA — September 16, 2026 Avacta Therapeutics announced clinical proof of mechanism for AVA6103, its next-generation controlled-release...

Raritan, New Jersey, U.S., September 18, 2026 Johnson & Johnson has announced that the European Medicines Agency’s Committee for...

Tokyo, Japan, September 17, 2026 Astellas Pharma Inc. has announced that the European Medicines Agency’s Committee for Medicinal Products...

Burr Ridge, Illinois, U.S., September 17, 2026 SkinCure Oncology has reported a new analysis suggesting that the annual number...

Irvine, California, U.S., September 18, 2026 Avenda Health, an artificial intelligence-powered medical technology company focused on prostate cancer care,...

New York, New York, September 17, 2026 DarioHealth Corp. has announced a new contract with one of New Jersey’s...

New York, New York, September 17, 2026 Nuvation Bio Inc. has announced that the U.S. Food and Drug Administration...